[Federal Register Volume 78, Number 32 (Friday, February 15, 2013)]
[Notices]
[Page 11164]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-03483]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Intent To Grant an Exclusive License of U.S. Government-Owned 
Invention

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 35 U.S.C. 209(e), and 37 CFR 404.7 
(a)(1)(i) and 37 CFR 404.7 (b)(1)(i), announcement is made of the 
intent to grant an exclusive, revocable license to the invention 
claimed in U.S. Patent Application Serial No. 11/525,574, filed 
September 22, 2006, entitled ``Antibodies with Simultaneous Subsite 
Specificities to Protein and Lipid Epitopes,'' to Avanti Polar Lipids 
with its principal place of business at 700 Industrial Park Drive, 
Alabaster, AL 35007.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For licensing issues, Dr. Paul Mele, 
Office of Research & Technology Applications, (301) 619-6664. For 
patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808; 
both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Anyone wishing to object to grant of this 
license can file written objections along with supporting evidence, if 
any, within 15 days from the date of this publication. Written 
objections are to be filed with the Command Judge Advocate (see 
ADDRESSES).

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2013-03483 Filed 2-14-13; 8:45 am]
BILLING CODE 3710-08-P